Genesis Drug Discovery & Development

Genesis Drug Discovery & Development (GD3), the contract research arm of Genesis Biotechnology Group, brings together discovery, laboratory, preclinical and clinical capabilities in one organization. It supports programs from target discovery through IND filing and management of Phase I–III trials, including medicinal chemistry, biochemistry and bioanalysis, disease models, PK/PD and toxicology. STATKING Clinical Services is a legacy name whose former domain now resolves to GD3.